TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Kenvue Inc. (KVUE)

Consumer Defensive Household & Personal Products
19.20 $
-0.4% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Kenvue Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Trading Day

Previous Close
19.30$
Open
19.20$
Day High
19.30$
Day Low
19.00$
Volume
22,360,382shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
14.10 $ 22.20 $
10/16/2025 08/04/2025

Current price 19.20 $ — 63% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
35.8$B
Shares Outstanding
1,920Mio.
Float
99.9%
Beta
0.4

Performance

Perf. 1M
8.10%
Perf. 3M
10.20%
Perf. 6M
13.40%
YTD Performance (%)
9.30%
52-Week-High Distance
-17.1%
Perf. 1Y
-6.09%
Perf. 3Y
-8.21%
Perf. 5Y
-21.04%
Perf. Since Inception
-19.19%

Technical Indicators

MA 38 Days
18.90$
MA 50 Days
18.50$
MA 200 Days
17.50$
RSI (14)
53.2
Volatility 30 Days
23.2%
Volatility 250 Days
33.0%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
23.1
Forward P/E
16.7
PEG
1.6
P/B
3.5
P/S
2.3
EV/EBITDA
13.9
Price/FCF
19.6

Profitability

Gross Margin
58.6%
EBIT Margin
21.6%
Net Margin
10.6%
Return on Equity
15.7%
Return on Assets
7.1%

Balance Sheet & Safety

Equity Ratio
39.5%
Debt/Equity
7.0
Altman Z″
4.55
very solid
Piotroski
9 out of 9

Growth

Sales Growth Last Quarter
4.50%
EPS Growth Last Quarter
46.90%
Sales Growth (Year)
-2.14%
Forward Sales Growth
2.55%
Forward EPS Growth
4.10%

Dividend

Dividend Yield
4.37%
Dividend Per Share (TTM)
0.83$
Payout Ratio
95.9%
Years Without a Cut
2Years
Increase Streak
2Years

Quality & Screener

Stage
2
RS Rating
38
EPS Rating
76
very solid
Piotroski
9 out of 9
Fundamental Rating
B (62 out of 100)
Altman Z″
4.55

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 19.20 $
Price Target (average) 19.83 $

The price target sits 3.3% above the current price.

Consensus
Hold
Analyst Ratings
19
Distribution of Recommendations
Strong Buy 3
Buy 2
Hold 14
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 1.18 1.10 – 1.26 15,625 9.2% 16
12/31/2027 1.24 1.13 – 1.35 16,022 5.3% 16

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

6. Aug 2026 · before the open · Q2 2026
Expected Earnings per Share
0.32 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 3,662.0 $M Q4 2025: Q1 · 3,741.0 $M Q1 2025: Q2 · 3,839.0 $M Q2 2025: Q3 · 3,764.0 $M Q3 2025: Q4 · 3,780.0 $M Q4 2026: Q1 · 3,909.0 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.15 -11.00 3,662 -0.10 8.00 793 661
2025: Q1 0.17 8.50 3,741 -3.90 8.60 428 249
2025: Q2 0.22 621.50 3,839 -4.00 10.90 621 533
2025: Q3 0.21 4.00 3,764 -3.50 10.60 294 196
2025: Q4 0.17 13.20 3,780 3.20 8.70 854 744
2026: Q1 0.25 47.40 3,909 4.50 12.10 489 350
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2019 14,324 1,846 1,435 0.76 2,998
2020 14,467 -979 -879 -0.47 3,397 18,356 29,177
2021 15,054 2,920 2,078 1.10 334 20,399 27,929
2022 14,950 2,675 2,064 1.08 2,525 19,970 27,316
2023 15,444 2,512 1,664 0.87 3,168 11,211 27,851
2024 15,455 1,841 1,030 0.54 1,769 9,668 25,601
2025 15,124 2,704 1,470 0.76 2,197 10,765 27,076

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Kenvue Inc. ist ein Unternehmen für Verbrauchergesundheit in den USA, dem übrigen Nordamerika, Europa, dem Nahen Osten, Afrika, dem asiatisch-pazifischen Raum und Lateinamerika.

Employees21,780
HeadquartersSummit, NJ
Address1 Kenvue Way, 07901 Summit, United States
Phone908 874 1200
Websitekenvue.com
IPO Date4. May 2023
ISINUS49177J1025

Management

Management
Name Title Birth Year
Kirk L. Perry CEO & Director 1967
Michael P. Wondrasch Chief Technology & Data Officer 1969
Matthew Orlando General Counsel 1977
Carlton Lawson Group President of Europe, Middle East & Africa 1969
Heather R. Howlett Interim CFO & Chief Accounting Officer 1978
Meredith Stevens Chief Operations Officer 1963
Caroline Tillett Ph.D. Chief Scientific Officer 1972
Sofya Tsinis Head of Investor Relations
Jonathan Halvorson Chief Digital & Marketing Officer 1983
Anil Agarwal Head of Total Rewards

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?